Recordati stock after-hours at EUR 52.73: plus 0.34 percent versus the prior close
Published on 10/01/2026 at 19:36 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Recordati stock was at EUR 52.73 after-hours at 7:32 p.m. CEST on October 1, 2026, up 0.34 percent versus the prior close at Lang & Schwarz.
Recordati stock during the October 1 session
The prior close at Lang & Schwarz was EUR 52.55. The further course of after-hours trading at Lang & Schwarz until 11:00 p.m. CET/CEST is shown by the continuously updated real-time quote of Recordati stock.
Recordati-led financing supports rare-disease program
Orvida Pharma announced on September 15, 2026, that it had completed an interim financing led by Recordati, alongside continued participation from Orvida’s existing shareholders. The company said the proceeds will support further development of ontivatrep, an oral TRPV3 inhibitor, and additional programs for rare genetic skin diseases. Orvida expects Phase 1b topline results in Olmsted syndrome by the end of 2026, according to the GlobeNewswire release.
Separately, Reuters reported on September 14, 2026, that activist investor Palliser Capital had urged Recordati’s board to withdraw support for Respighi BidCo’s EUR 51.29-per-share takeover offer. Reuters said the offer, launched by CVC Capital Partners and Groupe Bruxelles Lambert, was scheduled to close on October 15, 2026, and that Palliser called for a price of at least EUR 60 per share. The report is available from Reuters.
